~~<i id='9FFA1497B9'><strike id='9FFA1497B9'><tt id='9FFA1497B9'><pre id='9FFA1497B9'></pre></tt></strike></i>~~

Home» leisure time» knowledge

knowledge

author：comprehensive 2025-09-28 21:18:15 Page View：7

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?
Next article： Dobbs anniversary: the lost opportunity of abortion as health care

comprehensive

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Physicians and social media: If you see something, say something?

AfterJoannaGaines,co-hostofHGTV's"FixerUpper,"shownherewithherhusband,Chip,postedanultrasoundofherba

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

App could help diagnose ear infections more accurately — and at home

AUWSchoolofMedicineprofessorpracticesusingtheappandfunneltocheckhisdaughter'sear.DennisWise/Universi